Home LiteratureArticle Details
PMID: 10982390 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

A role for both Ets and C/EBP transcription factors and mRNA stabilization in the MAPK-dependent increase in p21 (Cip-1/WAF1/mda6) protein levels in primary hepatocytes.

Molecular biology of the cell ·Vol. 11 ·No. 9 ·2000-09-00 ·Pages 2915-32

Park JS, Qiao L, Gilfor D, Yang MY, Hylemon PB, Benz C, Darlington G, Firestone G, Fisher PB, Dent P

Abstract

In primary hepatocytes and HepG2 hepatoma cells, prolonged activation of the p42/44 mitogen-activated protein kinase (MAPK) pathway is associated with a reduction in DNA synthesis, mediated by increased expression of the cyclin-dependent kinase inhibitor protein p21 (Cip-1/WAF1/mda6) (p21). This study was performed to evaluate the contribution of transcriptional and post-transcriptional regulation in this response. Prolonged activation of the MAPK pathway in wild-type or p21 null hepatocytes caused a large decrease and increase, respectively, in DNA synthesis. Prolonged activation of the MAPK pathway in either wild-type or p21 antisense HepG2 cells also caused large decreases and increases, respectively, in DNA synthesis. MAPK signaling increased the phosphorylation of the transcription factors Ets2, C/EBPalpha, and C/EBPbeta, and rapidly increased transcription from the p21 promoter via multiple Ets- and C/EBP-elements within the enhancer region. Eight hours after MAPK activation, loss of C/EBPbeta or Ets2 function significantly reduced MAPK-stimulated transcription from the p21 promoter and abolished increased p21 protein expression. At this time, MAPK signaling increased both p21 mRNA and p21 protein stabilities that were also demonstrated to be essential for a profound increase in p21 protein levels. Thirty-six hours after MAPK activation, transcription from the p21 promoter was still significantly reduced in cells without either C/EBPbeta or Ets2 function; however, these cells were now capable of exhibiting a partial increase in p21 protein expression. In contrast, loss of C/EBPalpha function modestly reduced MAPK-stimulated transcription from the p21 promoter but strongly inhibited the ability of prolonged MAPK activation to increase protein levels of p21. This data suggested that prolonged enhancement of p21 protein levels may be under posttranscriptional control. In agreement with this hypothesis, prolonged MAPK signaling further increased p21 mRNA stability at 36 h, compared with the 8-h time point. Our data argue that MAPK signaling increased p21 promoter activity via multiple transcription factors, which alone were insufficient for a robust prolonged increase in p21 protein levels in primary hepatocytes, and that to increase p21 protein levels also required enhanced stabilization of p21 mRNA and p21 protein. Collectively, these data suggest that loss of transcription factor and mRNA/protein stabilization functions correlates with an inability of MAPK signaling to cause growth arrest versus proliferation in primary hepatocytes.

MeSH Terms
Animals CCAAT-Enhancer-Binding Proteins/metabolism Carcinoma, Hepatocellular/metabolism Cells, Cultured Cyclin-Dependent Kinase Inhibitor p21 Cyclins/deficiency,genetics,metabolism Hepatocytes/cytology,drug effects,metabolism Humans Liver Neoplasms/metabolism Male Mice Mice, Inbred C57BL Mice, Knockout Mitogen-Activated Protein Kinases/metabolism Promoter Regions, Genetic Proto-Oncogene Proteins/metabolism Proto-Oncogene Proteins c-ets RNA, Messenger/metabolism Signal Transduction Tamoxifen/analogs & derivatives,pharmacology Transcription Factors/metabolism Transcription, Genetic/drug effects Tumor Cells, Cultured
Chemicals
CCAAT-Enhancer-Binding Proteins CDKN1A protein, human Cdkn1a protein, mouse Cyclin-Dependent Kinase Inhibitor p21 Cyclins Proto-Oncogene Proteins Proto-Oncogene Proteins c-ets RNA, Messenger Transcription Factors Tamoxifen afimoxifene Mitogen-Activated Protein Kinases
Authors & Affiliations
10 authors, click to expand affiliations / ORCID
Park J S
Departments of Radiation Oncology, Medical College of Virginia, Virginia Commonwealth University, Richmond, Virginia 23298, USA.
Qiao L
Gilfor D
Yang M Y
Hylemon P B
Benz C
Darlington G
Firestone G
Fisher P B
Dent P
References (56)
56 references, click to expand
  1. Roles for basal and stimulated p21(Cip-1/WAF1/MDA6) expression and mitogen-activated protein kinase signaling in radiation-induced cell cycle checkpoint control in carcinoma cells.
    Mol Biol Cell. 1999 Dec;10(12):4231-46 PMID: 10588655
  2. CCAAT/enhancer-binding protein alpha (C/EBP alpha) inhibits cell proliferation through the p21 (WAF-1/CIP-1/SDI-1) protein.
    Genes Dev. 1996 Apr 1;10(7):804-15 PMID: 8846917
  3. Growth factor dependence of progression through G1 and S phases of adult rat hepatocytes in vitro. Evidence of a mitogen restriction point in mid-late G1.
    J Biol Chem. 1996 May 10;271(19):11484-92 PMID: 8626707
  4. Differential regulation of hepatocyte DNA synthesis by cAMP in vitro in vivo.
    Am J Physiol. 1996 Nov;271(5 Pt 1):G780-90 PMID: 8944691
  5. Mutational analysis of the p53 and K-ras genes and allelotype study of the Rb-1 gene for investigating the pathogenesis of combined hapatocellular-cholangiocellular carcinomas.
    Jpn J Cancer Res. 1996 Oct;87(10):1056-62 PMID: 8957064
  6. Regulation of cyclin-dependent kinase inhibitor p21(WAF1/Cip1/Sdi1) gene expression in hepatic regeneration.
    Hepatology. 1997 Mar;25(3):557-63 PMID: 9049198
  7. Liver regeneration.
    Science. 1997 Apr 4;276(5309):60-6 PMID: 9082986
  8. CCAAT/enhancer-binding protein delta gene expression is mediated by APRF/STAT3.
    J Biochem. 1997 Apr;121(4):731-8 PMID: 9163525
  9. Differential regulation of the mitogen-activated protein and stress-activated protein kinase cascades by adrenergic agonists in quiescent and regenerating adult rat hepatocytes.
    Mol Cell Biol. 1997 Jul;17(7):3556-65 PMID: 9199291
  10. p53-independent induction of p21WAF1/CIP1 expression in pericentral hepatocytes following carbon tetrachloride intoxication.
    Cell Growth Differ. 1997 Sep;8(9):951-61 PMID: 9300178
  11. Antioxidants enhance the cytotoxicity of chemotherapeutic agents in colorectal cancer: a p53-independent induction of p21WAF1/CIP1 via C/EBPbeta.
    Nat Med. 1997 Nov;3(11):1233-41 PMID: 9359698
  12. CCAAT/enhancer binding protein alpha regulates p21 protein and hepatocyte proliferation in newborn mice.
    Mol Cell Biol. 1997 Dec;17(12):7353-61 PMID: 9372966
  13. Antioxidant-induced nuclear translocation of CCAAT/enhancer-binding protein beta. A critical role for protein kinase A-mediated phosphorylation of Ser299.
    J Biol Chem. 1997 Nov 28;272(48):30356-61 PMID: 9374525
  14. Comparison of cellular characteristics between human hepatoma cell lines with wild-type p53 and those with mutant-type p53 gene.
    Acta Med Okayama. 1997 Dec;51(6):313-9 PMID: 9439773
  15. Role of the CCAAT/enhancer binding protein-alpha transcription factor in the glucocorticoid stimulation of p21waf1/cip1 gene promoter activity in growth-arrested rat hepatoma cells.
    J Biol Chem. 1998 Jan 23;273(4):2008-14 PMID: 9442037
  16. Newly synthesized Rho A, not Ras, is isoprenylated and translocated to membranes coincident with progression of the G1 to S phase of growth-stimulated rat FRTL-5 cells.
    J Biol Chem. 1998 Feb 6;273(6):3649-53 PMID: 9452494
  17. Role of cyclin-dependent kinases and their inhibitors in cellular differentiation and development.
    Curr Top Microbiol Immunol. 1998;227:57-103 PMID: 9479826
  18. The Ras/Rac1/Cdc42/SEK/JNK/c-Jun cascade is a key pathway by which agonists stimulate DNA synthesis in primary cultures of rat hepatocytes.
    Mol Biol Cell. 1998 Mar;9(3):561-73 PMID: 9487126
  19. The mitogen-activated protein (MAP) kinase cascade can either stimulate or inhibit DNA synthesis in primary cultures of rat hepatocytes depending upon whether its activation is acute/phasic or chronic.
    Biochem J. 1998 Mar 15;330 ( Pt 3):1451-60 PMID: 9494119
  20. Signals from Ras and Rho GTPases interact to regulate expression of p21Waf1/Cip1.
    Nature. 1998 Jul 16;394(6690):295-9 PMID: 9685162
  21. Alpha-adrenergic inhibition of proliferation in HepG2 cells stably transfected with the alpha1B-adrenergic receptor through a p42MAPkinase/p21Cip1/WAF1-dependent pathway.
    FEBS Lett. 1998 Sep 25;436(1):131-8 PMID: 9771908
  22. Roles of CCAAT/enhancer-binding proteins in regulation of liver regenerative growth.
    J Biol Chem. 1998 Nov 20;273(47):30843-6 PMID: 9812973
  23. p21(WAF1/CIP1) is upregulated by the geranylgeranyltransferase I inhibitor GGTI-298 through a transforming growth factor beta- and Sp1-responsive element: involvement of the small GTPase rhoA.
    Mol Cell Biol. 1998 Dec;18(12):6962-70 PMID: 9819384
  24. Cell type-specific transcriptional activation and suppression of the alpha1B adrenergic receptor gene middle promoter by nuclear factor 1.
    J Biol Chem. 1998 Nov 27;273(48):31784-7 PMID: 9822643
  25. Prolonged activation of the mitogen-activated protein kinase pathway promotes DNA synthesis in primary hepatocytes from p21Cip-1/WAF1-null mice, but not in hepatocytes from p16INK4a-null mice.
    Biochem J. 1998 Dec 15;336 ( Pt 3):551-60 PMID: 9841865
  26. Epidermal growth factor increases the level of the cyclin-dependent kinase (CDK) inhibitor p21/CIP1 (CDK-interacting protein 1) in A431 cells by increasing the half-lives of the p21/CIP1 transcript and the p21/CIP1 protein.
    Biochem J. 1999 Feb 1;337 ( Pt 3):599-606 PMID: 9895307
  27. p21WAF1 expression by an activator of protein kinase C is regulated mainly at the post-transcriptional level in cells lacking p53: important role of RNA stabilization.
    Biochem J. 1999 Feb 1;337 ( Pt 3):607-16 PMID: 9895308
  28. Control of cell cycle progression by c-Jun is p53 dependent.
    Genes Dev. 1999 Mar 1;13(5):607-19 PMID: 10072388
  29. C/EBPalpha regulates formation of S-phase-specific E2F-p107 complexes in livers of newborn mice.
    Mol Cell Biol. 1999 Apr;19(4):2936-45 PMID: 10082561
  30. Overexpression of c-Myc inhibits p21WAF1/CIP1 expression and induces S-phase entry in 12-O-tetradecanoylphorbol-13-acetate (TPA)-sensitive human cancer cells.
    Cell Growth Differ. 1999 Apr;10(4):223-30 PMID: 10319992
  31. Ras regulates the association of serum response factor and CCAAT/enhancer-binding protein beta.
    J Biol Chem. 1999 May 14;274(20):14224-8 PMID: 10318842
  32. Transcriptional repressor ERF is a Ras/mitogen-activated protein kinase target that regulates cellular proliferation.
    Mol Cell Biol. 1999 Jun;19(6):4121-33 PMID: 10330152
  33. Separation of C/EBPalpha-mediated proliferation arrest and differentiation pathways.
    Proc Natl Acad Sci U S A. 1999 Jun 22;96(13):7276-81 PMID: 10377405
  34. CDK inhibitors: positive and negative regulators of G1-phase progression.
    Genes Dev. 1999 Jun 15;13(12):1501-12 PMID: 10385618
  35. Transcriptional regulatory signals define cytokine-dependent and -independent pathways in liver regeneration.
    Semin Liver Dis. 1999;19(2):117-27 PMID: 10422195
  36. Up-regulation of telomerase in primary cultured rat hepatocytes.
    J Biochem. 1999 Aug;126(2):361-7 PMID: 10423530
  37. Inhibition of mutant p53 phosphorylation at serine 15 or serine 315 partially restores the function of wild-type p53.
    Biochem Biophys Res Commun. 1999 Aug 2;261(2):256-63 PMID: 10425175
  38. Optimization of a reverse transcription-polymerase chain reaction (RT-PCR) mass assay for low-abundance mRNA.
    Methods Mol Biol. 1998;105:351-71 PMID: 10427577
  39. The mitogen-activated protein kinase kinase/extracellular signal-regulated kinase cascade activation is a key signalling pathway involved in the regulation of G(1) phase progression in proliferating hepatocytes.
    Mol Cell Biol. 1999 Sep;19(9):6003-11 PMID: 10454547
  40. The Raf-1/MEK/ERK pathway regulates the expression of the p21(Cip1/Waf1) gene in chondrocytes.
    J Biol Chem. 1999 Oct 15;274(42):30273-9 PMID: 10514521
  41. Genetic evidence that stress-activated p38 MAP kinase is necessary but not sufficient for UV activation of HIV gene expression.
    Biochemistry. 1999 Oct 5;38(40):13055-62 PMID: 10529175
  42. HuR regulates p21 mRNA stabilization by UV light.
    Mol Cell Biol. 2000 Feb;20(3):760-9 PMID: 10629032
  43. Conserved chromosomal positions of dual domains of the ets protooncogene in cats, mice, and humans.
    Proc Natl Acad Sci U S A. 1986 Mar;83(6):1792-6 PMID: 3513188
  44. Differential expression of three C/EBP isoforms in multiple tissues during the acute phase response.
    J Biol Chem. 1992 Mar 15;267(8):5021-4 PMID: 1371993
  45. p53 gene abnormalities are closely related to hepatoviral infections and occur at a late stage of hepatocarcinogenesis.
    Cancer Res. 1994 Jan 1;54(1):231-5 PMID: 8261444
  46. Hepatic gene therapy: efficient gene delivery and expression in primary hepatocytes utilizing a conjugated adenovirus-DNA complex.
    Proc Natl Acad Sci U S A. 1993 Dec 15;90(24):11548-52 PMID: 8265587
  47. LAP (NF-IL-6), a tissue-specific transcriptional activator, is an inhibitor of hepatoma cell proliferation.
    EMBO J. 1994 Feb 15;13(4):851-60 PMID: 7906646
  48. Transcriptional regulation by extracellular signals: mechanisms and specificity.
    Cell. 1995 Jan 27;80(2):199-211 PMID: 7834740
  49. Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signaling.
    Cell. 1995 Jan 27;80(2):225-36 PMID: 7834742
  50. Involvement of the cell-cycle inhibitor Cip1/WAF1 and the E1A-associated p300 protein in terminal differentiation.
    Proc Natl Acad Sci U S A. 1995 Jun 6;92(12):5451-5 PMID: 7777529
  51. Absence of p53 gene mutation and infrequent overexpression of p53 protein in hepatoblastoma.
    J Pathol. 1995 Jul;176(3):243-7 PMID: 7674087
  52. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo.
    J Biol Chem. 1995 Nov 17;270(46):27489-94 PMID: 7499206
  53. Inhibition of cell proliferation by C/EBP alpha occurs in many cell types, does not require the presence of p53 or Rb, and is not affected by large T-antigen.
    Nucleic Acids Res. 1995 Nov 25;23(22):4726-33 PMID: 8524667
  54. Liver regeneration 3: Regulation of signal transduction during liver regeneration.
    FASEB J. 1996 Feb;10(2):215-27 PMID: 8641555
  55. Targeted in vivo expression of the cyclin-dependent kinase inhibitor p21 halts hepatocyte cell-cycle progression, postnatal liver development and regeneration.
    Genes Dev. 1996 Feb 1;10(3):245-60 PMID: 8595876
  56. Expression of human papilloma virus E7 protein causes apoptosis and inhibits DNA synthesis in primary hepatocytes via increased expression of p21(Cip-1/WAF1/MDA6).
    J Biol Chem. 2000 Jan 7;275(1):18-28 PMID: 10617580
Article Info
Journal
Molecular biology of the cell
Abbr.
Mol Biol Cell
ISSN
1059-1524
Published
2000-09-00
Pages
2915-32
Language
English
Region
United States
NLM ID
9201390
PMCID
PMC14965
Subset
IM
Grants
NCI NIH HHS · R01CA35675 · United States
NCI NIH HHS · R01 CA035675 · United States
NIDDK NIH HHS · R01DK52825 · United States
NIDDK NIH HHS · R01 DK052825 · United States
NCI NIH HHS · R01CA74468 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]